2-DE |
Two-dimensional gel electrophoresis |
AI |
Artificial Intelligence |
AML |
Acute myeloid leukemia |
APOAII |
Apolipoprotein-AII |
APOLLO |
Applied Proteogenomics Organizational Learning and Outcomes |
ART |
Antibiotic resistance |
AS |
Alternative splicing |
AST |
Antibiotic susceptibility testing |
CAF |
Cancer-associated fibroblasts |
CASK |
Calcium/calmodulin-dependent serine protein kinase |
CCA |
Cholangiocarcinoma |
CD |
Crohn’s disease |
CDI |
Clostridium difficile infection |
CEMIP |
Cell migration-inducing and hyaluronan-binding protein |
CHAT |
Cancer Hallmarks Analytics Tool |
CPTAC |
Clinical Proteomic Tumor Analysis Consortium |
CRC |
Colorectal cancer |
DAVID |
The Database for Annotation, Visualization and Integrated Discovery |
DDA |
Data dependent analysis |
DIA |
Data independent analysis |
DMS |
Differential ion mobility MS |
EDRN |
Early Detection Research Network |
EV |
Extracellular vesicles |
FASN |
Fatty acid synthase |
FFPE |
Formalin-fixed paraffin-embedded |
FMT |
Fecal microbiota transplantation |
Fn |
Fusobacterium nucleatum |
GELFREE |
Gel-eluted liquid fractionation entrapment electrophoresis |
HCC |
Hepatocellular carcinoma |
HGSC |
High-grade serous ovarian carcinoma |
HoC |
Hallmarks of Cancer |
hPOP |
Human Personal Omics Profiling |
HPP |
Human Proteomics Project |
HPRL |
Proteome Reference Library |
hTERT |
Human telomerase reverse transcriptase |
HUPO |
Human Protein Organisation |
IARC |
International Agency for Research on Cancer |
IBD |
Inflammatory bowel disease |
ICP |
Inductively coupled argon plasma |
ICPC |
International Cancer Proteogenome Consortium |
IHC |
Immunohistochemistry |
IPA |
Ingenuity pathway analysis |
iTRAQ |
Isobaric tagging for multiplexed relative and absolute protein quantitation |
LOXL-4 |
Lysyl oxidase-like 4 |
LPS |
Lipopolysaccharide |
LRG |
Leucine-rich α-2 glycoprotein |
LUAD |
Lung adenocarcinoma |
MAT2A |
Methionine adenosyltransferase 2a |
mdCAT |
Mass-defect-based carbonyl activated tag |
MDD |
Major depressive disorder |
MRM |
Multiple reaction monitoring |
MudPIT |
Multidimensional protein identification technology |
NNMT |
Nicotinamide N-methyltransferase |
NSCLC |
Non-small cell lung cancer |
NTME |
Nontumor microenvironment |
OS |
Overall survival |
PCT |
Pressure cycling technology |
PDAC |
Pancreatic ductal adenocarcinoma |
PHOENIX |
The Chinese Pilot Hub Of Encyclopedic Proteomix |
PPTT |
Plasmonic photothermal therapy |
PRM |
Parallel reaction monitoring |
PTMs |
Posttranslational modifications |
QSOX1 |
Quiescin sulfhydryl oxidase 1 |
QTOF |
Quadrupole time-of-flight |
RA |
Rheumatoid arthritis |
RBFOX3 |
RNA binding protein fox-1 homolog 3 |
ROS |
Reactive oxygen species |
RPMAs |
Reverse phase microarrays |
RPPA |
Reverse-phase protein microarray |
RFS |
Recurrence-free survival |
SAPs |
Single amino acid polymorphisms |
SCFAs |
short-chain fatty acids |
SDS-PAGE |
Sodium dodecyl sulfate polyacrylamide gel electrophoresis |
SERS |
Surface-enhanced Raman scattering |
SILAC |
Stable isotope labeling by/with amino acids in cell culture |
SRM |
Selective reaction monitoring |
suPAR |
Soluble urokinase-type plasminogen activator receptor |
SWATH-MS |
Sequential window acquisition of all theoretical mass spectra |
TCGA |
The Cancer Genome Atlas |
TME |
Tumor microenvironment |
TMT |
Tandem mass tag |
TNBC |
Triple negative breast cancer |
TOTT |
The Oncology Think Tank |
uPAR |
Urokinase plasminogen activator receptor |